• June 16-19, 2025
  • Boston Convention & Exhibition Center

Sessions

Loading

Immune System Biomarkers: Can Our Antibodies Predict How We Will React to Disease and Immunotherapy?

Thursday, June 06, 2024
Breakout Session
Diagnostics and Personalized Medicine
26A
A patient’s antibody profile is a measure of the reactivity of their immune system and a historical record of the diseases they’ve had in the past. As such, the antibodies a patient has can be predictive of how that patient will react to both disease and immunotherapy. Autoantibodies are causative elements of autoimmune diseases, but these antibodies are not solely related to autoimmune diseases. COVID-19 has highlighted that viral infection can cause immune systems to overreact, releasing autoantibodies, which can in part be responsible for some of the symptoms of PASC (Long COVID). This session will explore the contribution of autoantibodies to disease and treatment and their utility as a novel biomarker class that can augment existing biomarkers, supporting the goal of better patient stratification and precision medicine.
Moderator
Moira Gunn, PhD
Radio Host
BiotechNation
Speakers
Martin Gouldstone
Chief Executive Officer
Oncimmune
G. Scott Chandler, MD
Global Head, Personalized Health Care (PHC) Safety
F. Hoffmann-La Roche
Justina Fert-Bober, PhD
Project Scientist
Cedars Sinai Medical Center
Prem Premsrirut
CEO and President
Mirimus
Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS